Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Nervous glucose sensing regulates postnatal β cell proliferation and glucose homeostasis
David Tarussio, … , Marc Foretz, Bernard Thorens
David Tarussio, … , Marc Foretz, Bernard Thorens
Published December 16, 2013
Citation Information: J Clin Invest. 2014;124(1):413-424. https://doi.org/10.1172/JCI69154.
View: Text | PDF
Research Article Metabolism

Nervous glucose sensing regulates postnatal β cell proliferation and glucose homeostasis

  • Text
  • PDF
Abstract

How glucose sensing by the nervous system impacts the regulation of β cell mass and function during postnatal development and throughout adulthood is incompletely understood. Here, we studied mice with inactivation of glucose transporter 2 (Glut2) in the nervous system (NG2KO mice). These mice displayed normal energy homeostasis but developed late-onset glucose intolerance due to reduced insulin secretion, which was precipitated by high-fat diet feeding. The β cell mass of adult NG2KO mice was reduced compared with that of WT mice due to lower β cell proliferation rates in NG2KO mice during the early postnatal period. The difference in proliferation between NG2KO and control islets was abolished by ganglionic blockade or by weaning the mice on a carbohydrate-free diet. In adult NG2KO mice, first-phase insulin secretion was lost, and these glucose-intolerant mice developed impaired glucagon secretion when fed a high-fat diet. Electrophysiological recordings showed reduced parasympathetic nerve activity in the basal state and no stimulation by glucose. Furthermore, sympathetic activity was also insensitive to glucose. Collectively, our data show that GLUT2-dependent control of parasympathetic activity defines a nervous system/endocrine pancreas axis that is critical for β cell mass establishment in the postnatal period and for long-term maintenance of β cell function.

Authors

David Tarussio, Salima Metref, Pascal Seyer, Lourdes Mounien, David Vallois, Christophe Magnan, Marc Foretz, Bernard Thorens

×

Figure 9

Impaired regulation by glucose of autonomic nervous activity and loss of first-phase insulin secretion in NG2KO mice.

Options: View larger image (or click on image) Download as PowerPoint
Impaired regulation by glucose of autonomic nervous activity and loss of...
(A and B) Recordings of parasympathetic activity in control (A) and NG2KO (B) mice, in the basal state and after i.p. injection of glucose (dotted line). (C) Quantification of firing activity. (D and E) Recordings of sympathetic activity in control (D) and NG2KO (E) mice, in the basal state and after i.p. injection of glucose. (F) Quantification of sympathetic firing activity. Data are mean ± SEM; n = 5; **P < 0.01, ***P < 0.001 versus basal. (G) Plasma insulin levels in 8- to 10-week-old control and NG2KO mice in the fasted state and 2 and 30 minutes after i.p. glucose injection. (H) Blood glucose concentrations at the times of insulin measurements. Data are mean ± SEM; n = 6–9; **P < 0.01. (I) Glucose-stimulated insulin secretion from 8- to 10-week-old control and NG2KO islets. n = 4 for each perifusion. Data are mean ± SEM.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts